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Abstract 
 
Possession of a higher than average number of nevi has long been substantiated as 
one of several factors that predispose patients to malignant melanoma. Despite the 
relative certainty of this relationship, little is known about the relationship between the 
number of nevi a person possesses and risk of death from melanoma.  A cohort of 
melanoma patients was followed prospectively to determine if a significant relationship 
exists between number of nevi and increased mortality from melanoma.  Age at 
diagnosis, melanoma of the head and neck, increasing Breslow thickness and presence of 
mitoses all were associated with poorer survival in our multivariate analysis.  Existence 
of a dermal nevus at the site of melanoma was also associated with poorer survival, while 
solar elastosis and skin awareness were associated with improved survival.  Our study 
also suggests that having a large number of nevi increases the risk of death from 
melanoma more than two-fold.  Further research elucidating the prognostic indications of 
a high number of nevi possessed by melanoma patients could potentially lead to 
considerable advances in the classification, diagnosis, and therapy for cutaneous 
melanoma. 
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Introduction 
 
Individuals who have many nevi are at higher risk for developing melanoma.  In 
fact, a large number of nevi has been shown to be the strongest known risk factor for 
developing melanoma among Caucasians (Armstrong, 2004).   Even in the absence of 
clinically atypical nevi, a very high number of nevi (e.g., more than 100) have been 
shown to significantly increase risk for melanoma (Huynh et al., 2003).  Risk is based on 
the total number of nevi, not those at a particular anatomic site (Weinstock et al., 1989).   
 
Survival among melanoma patients has been shown to be influenced by 
pathologic characteristics such as tumor thickness (Breslow depth), histogenetic subtype, 
Clark level, microscopic satellites, ulceration, vascular invasion, mitotic rate and growth 
phase (Barnhill et al., 1996).  Regression and solar elastosis have been shown to be 
protective (Barnhill et al., 1996; Berwick et al., 2005). Tumor thickness is probably the 
most important pathologic prognostic factor in localized, cutaneous melanoma (Lemish et 
al., 1983; Heenan et al., 1991; Barnhill et al., 1996; Berwick et al., 2005).  In an analysis 
of prognostic factors for 17,600 melanoma patients, increasing tumor thickness was 
highly correlated with 10-year melanoma specific mortality (p<0.00001) (Balch et al., 
2001).  In one study, level of awareness of skin alterations is associated with improved 
survival and is probably another important prognostic factor (Berwick et al., 1996).  It is 
not clear that early detection of melanoma through skin self-examination reduces 
mortality, but one study indicated that it may decrease risk by up to 63% (Berwick et al., 
1996).  Melanoma has been associated with a worse prognosis when the site of origin is 
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the head or neck as opposed to the extremities (Lemish et al., 1983)  and females have 
been shown to have a higher survival rate than males (Clark et al., 1989).  These 
prognostic factors are potential confounders of survival studies. Despite the existence of 
extensive research that documents the risk for developing malignant melanoma with 
increasing numbers of nevi, a relationship between number of nevi and survival with 
melanoma has yet to be identified.   
 
Although the number of nevi has been shown to be determined by genetic factors, 
(Zhu et al., 1999; Bataille et al., 2000) environmental factors are also important for nevus 
development (Kefford et al., 2004).  Epidemiological studies in several countries have 
shown that exposure to excessive sunlight in childhood is associated with total number of 
nevi.  Habitual sun exposure, (Darlington et al., 2002) severe sunburns, (Green et al., 
1986; Dennis et al., 1996; Valiukeviciene et al., 2005) recent chronic sun exposure 
(Armstrong et al., 1986) and total cumulative sun exposure (Weiker et al., 2003; Bauer et 
al., 2005) have all been proposed as important types of sun exposure associated with 
increasing number of nevi.  Tendency to burn (Green et al., 1986; Heenan et al., 1991; 
Whiteman et al., 2005),  freckling (Green et al., 1986; Darlington et al., 2002; Whiteman 
et al., 2005), light eye color (Whiteman et al., 2005; Wachsmuth et al., 2005), light hair 
color (Whiteman et al., 2005; Wachsmuth et al., 2005), and light skin color (Patvlotsky et 
al., 1997; Whiteman et al., 2005) have also all been positively associated with number of 
nevi, although these findings vary between studies.  A higher prevalence of nevi has been 
found among individuals with moderately dark skin compared to the those with pale skin 
(Armstrong et al., 1986).  Increasing age has been shown to be associated with a 
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decreasing number of nevi (Green et al., 1986; Dennis et al., 1996; Schafer et al., 2006) 
and individuals with melanoma arising from the head or neck tend to have fewer nevi 
than those with melanoma arising on the trunk (Whiteman et al., 2003).   
 
We wanted to examine whether nevi might be a marker for a type of melanoma 
that has escaped growth controls and thus might be associated with survival with the 
disease.  Therefore, we conducted long-term follow up (average 16 years) of subjects 
who had been enrolled in a population-based case control study in Connecticut (Berwick 
et al., 1996; Berwick et al., 2005). 
 
Methods 
 
The original study on melanoma was approved by the Institutional Review Boards 
at Yale University, the State of Connecticut Department of Health and the University of 
New Mexico Health Sciences Center, as well as the hospitals where patients had been 
diagnosed.  Potential subjects with melanoma were identified through the Rapid Case 
Ascertainment System (RCA), a shared resource of the Cancer Prevention Research Unit 
for Connecticut and acts as an agent of the Connecticut Tumor Registry (CTR).  All 
participating subjects signed informed consent.  Eligibility was based on diagnosis of a 
first primary invasive melanoma between the dates of January 15, 1987 and May 15, 
1989, residence in the state of Connecticut, being of Caucasian race, and being 18 years 
old or greater.  All biopsies and re-excisions were reviewed by a single 
dermatopathologist (R.L. Barnhill) for standardization. 650 eligible patients, or 75% of 
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those eligible, were interviewed and of these nevus counts were obtained for 80 percent 
of subjects  
 
Trained, registered nurses conducted in-person interviews with all the selected 
study participants. They interviewed the patients with a structured questionnaire to assess 
the following information:  age at melanoma diagnosis, sex, level of educational 
attainment, history of severe sunburns, skin examination practices, skin awareness, site of 
melanoma, use of sunlamps, sunscreen use within the last 10 years, sunscreen use before 
age 15, tanning ability, skin color, and lifetime intermittent sun exposure.  The sun 
exposure index that we used quantified sun exposure history by summing the total 
intermittent recreational sun exposure histories and has been previously described in 
detail (Berwick et al., 1996).  Intermittent sun exposure was measured as described 
previously (Berwick et al., 1996).  Nurses trained in techniques of skin examination 
recorded skin color on the inner aspect of the upper arm.  Information regarding skin 
type, sunburn history, skin examination and skin awareness was gathered by asking the 
following questions:  
 
Skin type.  After repeated and prolonged exposure to sunlight, would your skin 
become:  tan, very brown and deeply tanned or moderately tanned or only mildly tanned 
due to a tendency to peel; no tan, only freckled or no suntan at all. 
 
Sunburn history.  Have you ever been sun burnt severely enough to cause pain 
for 2 or more days or blisters?  
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Skin examination.  Individuals were classified as skin self-examiners if they 
answered positively to either of the following two questions:  1) Did you ever (in your 
life) carefully examine your own skin?  By this I mean actually check surfaces of your 
skin deliberately and purposefully?; or 2)  Has someone other than a physician ever 
carefully examined areas of your skin on purpose? 
 
Skin awareness.  [Before your recent biopsy] did you ever think about your skin, 
how it looked, whether there were any changes, or whether there were any abnormal 
marks?  Individuals that answered that they were aware of changes or abnormalities were 
classified as having skin awareness, while those that answered negatively or answered 
that they were aware only of cosmetic or other changes were not classified as having skin 
awareness.   
 
The trained, registered nurses also counted and recorded nevi greater than 2mm in 
largest diameter on the arms and backs of subjects who consented.  A standardized 
method was used that only included the counting of nevi proximal to the styloid process 
on both arms.  Each arm was divided into four sections and the nurses recorded which 
sections were examined for nevi.  Flat nevi of 2 mm or more in diameter and greater were 
recorded, and raised nevi of any size were included if they were visibly raised.  Nevus 
counts were performed in an organized fashion beginning with the counting of raised true 
nevi on both arms followed by inspection for junctional or lentigo simplex nevi and 
finally, nevi 5mm or greater in largest diameter were counted for both arms.  The patients 
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were examined for palpable nevi by visual inspection first, while palpation was only 
utilized to distinguish between raised and flat nevi.  Inspection of the arms was concluded 
with observation and recording of the color of the skin on the inner aspect of the upper 
arm of the patient (dark/black, moderately dark, medium, fair, very fair).  The back was 
assessed in a similar manner and the proportion of the back that was able to be examined 
was noted by the interviewer and classified as one the following categories:  none, all, 
upper quarter, upper half, and upper ¾ of the back. This allowed for the differences in the 
proportion of the back that was examined to be taken into account in the analysis. All 
large nevi on the arms and back were diagramed by the interviewer and the largest mole 
from the patient’s back was recorded on a mannequin. 
 
Pathologic characteristics of melanoma that were recorded included tumor 
thickness, number of mitoses per millimeter squared (mitotic index), presence of solar 
elastosis, and Clark level.  Presence of a co-existing nevus and the type of nevus (dermal, 
congenital, dysplastic and other) was also recorded.  Follow-up was performed by the 
RCA throughout the study period up until the August 2008 in all diagnosing institutions 
in Connecticut.  Follow-up included a review of death certificates and reports to the CTR, 
as well as mailings and telephone calls to patients, their spouses, and their primary 
physicians if necessary.  The National Death Index was queried for all those for whom 
we did not have death certificates. The median follow up for all case subjects was 16.1 
years and the range was 0 to 19.9 years.   
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Statistical analysis consisted of frequency distributions, and cross-tabulations.  
Covariates that were determined to have a significant correlation with number of nevi 
were included in univariate models measuring death as the outcome.  If the p-value from 
a specific univariate model was less than 0.16, then that covariate was included in the 
multivariate analysis, using Cox proportional hazard modeling with time to mortality 
from melanoma as the outcome.  Potential confounders were assessed by comparing the 
hazard ratio for survival and nevi with each variable that might modify the hazard ratio 
by 15% or more. 
 
We evaluated the distribution of nevi and divided nevi into two groups based on 
the top 25th percentile and the lower 75th percentile. We then compared selected 
variables by the two groups of nevi (Table 1).  The following covariates were included: 
sex, age at diagnosis, ability to tan, history of sunburn, skin color, presence of solar 
elastosis (a histologic indicator of cutaneous sun damage), anatomic site of melanoma, 
history of sun exposure, skin examination, sunlamp use, tumor thickness, presence of 
mitosis, Clark level, education, co-existing nevus, dermal nevus and skin awareness. 
 
Results 
 
 In follow up of this cohort, 98 (18.8%) of the 520 patients died of melanoma and 
126 (24.2%) died of other causes over the twenty-year period. Younger participants were 
significantly more likely to possess more than 28 nevi on their arms and back (P = <.01) 
as were those with the ability to tan after prolonged sun exposure (P = .03).  Individuals 
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with melanoma arising from the head or neck were significantly more likely to be in the 
low nevus group (P = .01).  Skin examination was associated with more nevi (P = .07) 
and solar elastosis was associated with fewer nevi (P = .05), but these were of borderline 
significance.  Time to death from melanoma was modeled using univariate Cox hazard 
models to obtain the hazard ratio for each covariate (Table 2).  Eleven variables were 
significant in this analysis.  High nevus count was associated with an increased risk of 
death from melanoma (HR = 1.7, 95% CI = 1.1 to 2.6, P = .01).  Men were more likely to 
die from melanoma than were women (HR = 1.5, 95% CI = 1.0 to 2.3, P =.04).  
Increasing age at diagnosis was associated with a decrease in survival (HR for every 1-
year increase in age = 1.02, 95% CI = 1.01 to 1.03, P = < .01), as was melanoma of the 
head and neck compared to melanoma of other sites (HR= 1.8, 95% CI = 1.1 to 3.0, P = 
.02), the presence of mitoses (HR = 8.9, 95% CI = 4.3 to 18.3, P = <.01), and increasing 
Breslow thickness and Clark level (see Table 2).  Several factors associated with sun 
exposure were protective:  A higher amount of sun exposure (HR for heavy or very heavy 
sun exposure compared to light or moderate sun exposure = 0.6, 95% CI = 0.4 to 0.9, P = 
0.02), the use of sunlamps (HR = 0.3, 95% CI = 0.2 to 0.7, P = <0.01), skin awareness 
(HR = 0.5, 95% CI = 0.3 to 0.8, P = <0.01) and education greater than high school (HR = 
0.7, 95% CI = 0.4 to 1.0, P = .03).  The presence of solar elastosis was also protective 
(HR = 0.7, 95% CI = 0.5 to 1.0, P = .06) but of borderline significance. Additional 
covariates in the univariate analyses were prognostic, but not statistically significant:  
The presence of a dermal nevus at the site of melanoma (HR = 1.5, 95% CI = 0.9 to 2.5, 
P = 0.16) and history of a severe sunburn (HR = 0.7, 95% CI = 0.5 to 1.1, P = 0.14).   
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For the multivariate analysis (Table 3), we included all variables from the 
univariate models (Chi-square and Cox univariate) with a P value ≤ 0.16.  Sex was forced 
into the model due to its importance in the literature as a prognostic indicator for death 
from melanoma.  Clark level was excluded from the multivariate analysis because Clark 
level and Breslow thickness had a Spearman correlation coefficient of 0.79 and were 
considered to be collinear.  In multivariate analysis a high number of nevi (HR = 2.4, 
95% CI 1.5-3.7), older age at diagnosis (HR = 1.03, 95% CI 1.01-1.04, melanoma on the 
head or neck (HR = 2.0, 95%, CI = 1.2 to 3.4), presence of solar elastosis (HR = 0.6, 
95%, CI = 0.3 to 0.9), greater Breslow thickness (HR  for 0.76 mm to ≤3.60 mm  = 3.1, 
95% CI = 1.9 to 5.2; HR > 3.60mm = 4.7, 95% CI = 2.6 to 8.5), any mitoses (HR = 4.2, 
95% CI 1.9-9.1) , presence of a dermal nevus (HR = 1.8, 95%, CI = 1.0 to 3.3), and skin 
awareness (HR = 0.5, 95%, CI = 0.3 to 0.9) were all significantly associated with 
melanoma mortality.          
 
Discussion 
 
The results of this melanoma mortality study with twenty years of follow up 
further support the significance of previously known prognostic indicators.  In our 
multivariate analysis, age at diagnosis, melanoma of the head and neck, increasing 
Breslow thickness and presence of mitoses all were associated with poorer survival.  
Existence of a dermal nevus at the site of melanoma was also associated with poorer 
survival in our study, but to our knowledge this characteristic has not been well studied.  
Presence of solar elastosis and skin awareness were associated with improved survival, as 
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was noted in a five-year follow-up study using the same patient database (Berwick et al., 
2005).  Interestingly, our study suggests that having a large number of nevi increases the 
risk of death from melanoma more than two-fold.  The association of increasing number 
of nevi with mortality from melanoma was independent of its significant associations 
with age at diagnosis, skin type and anatomic site of melanoma.  In the previous five-year 
follow-up study with this data, the association between nevus counts and death from 
melanoma was not statistically significant (Berwick et al., 2005), but this has changed 
with the longer follow-up period.  To our knowledge, number of nevi has not previously 
been evaluated as a prognostic factor.  
 
In the US, New Zealand and Canada, incidence rates of the more aggressive 
melanoma on the ears, scalp and neck were higher in males compared to females 
(Bulliard et al., 1997).  The differences in common melanoma sites between males and 
females likely reflects distinct patterns of site-specific UV radiation (Green et al., 1993; 
Bulliard et al., 1997; Elwood et al., 1998).  
  
There are multiple factors that could confound the association between nevi and 
mortality.  For example, age is related to both mortality and number of nevi, because as 
people age past a certain point, their chance of dying tends to increase, while their 
number of nevi tends to decrease (Dennis et al., 1996).  These factors might mitigate 
against each other.  Inevitably, additional confounders may exist that could potentially 
contribute to error in the study.  For example, there is a possibility that use of sunscreen 
and protective clothing could be inversely associated with mortality from melanoma.  
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These variables were not included in the multivariate analysis even though their 
quantification was attempted in the survey but people generally have poor memory of 
these factors and in a reproducibility study, sunscreen use was not reliably recalled 
(unpublished data).1  In addition, sunscreen use was not frequent in the 1980’s, when the 
study was conducted.  Other data that were gathered, such as sun exposure, could be 
relatively unreliable either because of recall bias or because people simply have poor 
memories of sunburn history.  Finally, nevus counts are complete for only 80% of the 
cohort, because this process was initiated after the study had begun. 
 
Despite the presence of certain limitations in this study, there are a number of 
inherent strengths.  The fifteen-year follow-up allowed for a greater number of outcomes 
of interest (death) as compared to a previous study using the same data with a five-year 
follow-up.  The long time frame also increased the chance that covariate patterns related 
to mortality of melanoma would be elucidated and adjusted for more appropriately.  The 
study design strengthened the analysis of our data because a comprehensive initial survey 
was used to collect information from participants.  A unique feature of this study was that 
skin examination characteristics were collected and could be adjusted for in the 
multivariate analysis.  The vital status for participants who did not respond to mailed 
follow-up questionnaires was ascertained by phone calls to the patient, patient’s spouse 
or patient’s physician.  Using this method instead of solely relying upon death certificate 
information minimized misclassifications of cause of death, which allowed for more 
complete and accurate evaluation of the relationship between number of nevi and 
                                                 
1 Berwick M, unpublished data.  A kappa for memory of sunscreen use was 0.1 
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survival.   Finally, the use of a single pathologist for the collection of melanoma 
characteristics such as associated solar elastosis and Clark level also helped to 
standardize results and avoid inter-observer variation. 
  
The association of a high number of nevi with increased mortality from melanoma 
may be explained by two hypotheses.  First, a separate, more aggressive oncogenic 
pathway may be associated with patients in the high nevi group.  The divergent pathway 
model developed by Whiteman classifies the pathogenesis of melanoma into two 
pathways, one characterized by environmental induction and p53 over-expression and 
another characterized by pigment cell instability (Whiteman et al., 1998).   It has been 
suggested that individuals with fewer nevi require repeated exposure to sunlight in order 
to drive carcinogenesis because they are more likely to develop melanomas on high sun 
exposure areas such as the head and neck, while those with many nevi, who are more 
likely to develop melanoma of the trunk, may possess host factors that drive 
carcinogenesis after minimal sunlight exposure (Whiteman et al., 2003).  Therefore, it is 
plausible that the oncogenic pathway characterized by pigment cell instability is 
associated with a higher number of nevi, and may lead to more aggressive melanoma and 
a worse prognosis.   
 
Alternatively, the pathogenesis of melanoma in patients of both the high and low 
nevi groups may follow very similar pathways, but patients in the high nevi group may be 
missing a genetic checkpoint.  The absence of this checkpoint may allow for a more 
aggressive progression of melanoma and may also permit the development of a higher 
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number of nevi.  The etiology of nevi and melanoma appear to be similar in some 
respects, as the gene CDKN2A has been associated with the development of melanoma 
(Kefford et al., 1999; Zhu et al., 1999; Chaudru et al., 2004) and possibly with the 
development of nevi as well (Zhu et al., 1999).  For example, a subset of people with 
certain familial nevus disorders such as dysplastic nevus syndrome (DNS) possess a 
CDKN2A mutation and go on to develop melanoma (Zhu et al., 1999).  Further 
characterization of the biochemical pathways leading to the development of both nevi and 
melanoma will be necessary, however, before either of these hypothesis can be 
appropriately supported. 
 
In summary, we found that a high number of nevi is associated with poorer 
survival from melanoma, though little is known about the specific mechanism by which 
this may occur.  Confirmation of our results may contribute to evidence in the field of 
oncology that suggests that genetic susceptibility in patients with cancer may possess 
distinct features of natural history that affect prognosis.  Prognostic variables that can be 
inexpensively and non-invasively obtained from patients may provide welcome new 
capabilities in clinical medicine.  A related example is the finding that women who were 
diagnosed with breast carcinoma and who had a first-degree family history of breast 
carcinoma had half the risk of dying compared to those in sporadic cases (Malone et al., 
1996).  Like family history, the number of nevi present on a patient can easily be 
obtained clinically.  Further research elucidating the prognostic implications of a high 
number of nevi in melanoma patients could potentially lead to advances in the 
classification, diagnosis, therapy, and prognosis of melanoma. 
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1.  Effect of covariates on nevus count. 
  
             Number of Nevia 
 Low (n =453)  High (n = 96) P value 
 n (%) n (%)      
Sex 
Male 194 (72.9) 72 (27.1) .22 
Female 197 (77.6) 57 (22.4)  
Age at diagnosis 
<30 19 (79.2) 5 (20.8) <.01 
30-39 47 (64.4) 26 (35.6) 
40-49 59 (62.1) 36 (37.9) 
50-59 79 (76.0) 25 (24.0) 
60-69 90 (81.8) 20 (18.2) 
70+ 97 (85.1) 17 (14.9)    
Skin type 
Tan 240 (72.1) 93 (27.9) .03 
No tan 139 (80.8) 33 (19.2)  
Skin  color 
Very fair/fair 277 (75.3) 91 (24.7) .95 
Medium 114 (79.1) 38 (20.9)  
Anatomic site 
Head and neck 65 (86.7) 10 (13.3) .01 
Other 326 (73.3) 119 (26.7)  
Solar elastosis  
Absent 135 (71.1) 55 (28.9) .05 
Present 236 (80.4) 69 (19.6)  
Breslow thickness 
< 0.76 174 (75.7) 56 (24.3) .91 
0.76 – 1.69 113 (73.4) 41 (26.6) 
1.70 – 3.60 65 (74.7) 22 (25.3) 
> 3.60 36 (78.3) 10 (21.7) 
Clark level    
II 139 (80.3) 34 (19.7) .26 
III 101 (71.6) 40 (28.4) 
IV 124 (72.5) 47 (27.5) 
V 15 (75.0) 5 (25.0) 
Mitotic figure(s) 
Absent 149 (74.9) 50 (25.1) .73 
Present 216 (76.4) 78 (23.6) 
Co-existing nevus 
Yes 110 (71.0) 45 (29.0) .25 
No 261 (75.9) 83 (24.1) 
Dermal nevus2 
Yes 43 (69.4) 19 (30.6) .33 
No 332 (75.1) 110 (24.9) 
Total sun exposure 
Light/moderate 150 (79.4) 39 (20.6) .08  
Heavy/very heavy 232 (72.5) 88 (27.5)  
Severe sunburn 
Yes 264 (77.4) 77 (22.6) .09 
No 125 (70.6) 52 (29.4)  
Sunlamp use 
Yes 87 (77.0) 26 (23.0) .62 
No 304 (74.7) 103 (25.3) 
Education 
Up to high school 157 (75.5) 51 (24.5) .90  
Greater than  234 (75.0) 78 (25.0) 
high school 
Skin examination 
Yes 95 (69.3) 42 (30.7) .07 
No 296 (77.3) 87 (22.7) 
Skin awareness 
Yes 119 (75.8) 38 (24.2) .83 
No 272 (74.9) 91 (25.1) 
                                                 
2 Dermal nevus is a subset of co-existing nevus.  Please see text.  
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2.  Predictors of risk of death from melanoma in a population-based study of residents 
from Connecticut. 
 
      No. of    Hazard ratio  
  Total melanoma  (95% confidence 
Variable    no.3    deaths     interval)  P value 
 
Number of nevi    
< 28  171 64 1.0 (referent) .01 
28+ 53 34 1.7 (1.1 to 2.6) 
Sex 
Female  85 40 1.0 (referent) .04 
Male  139 58 1.5 (1.0 to 2.3) 
Age at diagnosis4 
1-year increase   1.02 (1.01 to 1.03) <.01   
Skin type 
No tan   75 31 1.0 (referent) 1.0 
Tan  139 62 1.0 (0.6 to 1.5)  
Skin  color 
Medium 63 25 1.0 (referent) .30 
Very fair/fair 161 73 1.3 (0.8 to 1.0)    
Anatomic site  
Other  174 77 1.0 (referent) .02 
Head and neck 50 21 1.8 (1.1 to 3.0) 
Solar elastosis  
Absent  64 46 1.0 (referent) .06 
Present  152 49 0.7 (0.5 to 1.0) 
Breslow thickness 
< 0.76  76 10 1.0 (referent) 
0.76 – 1.69 59 28 4.3 (2.1 to 8.9) <.01 
1.70 – 3.60 53 37 12.4 (6.2 to 25.0) <.01 
> 3.60  35 23 17.9 (8.5 to 37.6) <.01 
Clark level   
II  53 4 1.0 (referent)  
III  57 23 7.5 (2.6 to 21.6) <.01 
IV/V  107 65 17.9 (6.5 to 49.2) <.01 
Mitotic figure(s) 
Absent  65 8 1.0 (referent) <.01 
Present  150 88 8.9 (4.3 to 18.3) 
Co-existing nevus  
No  156 65 1.0 (referent) .97 
Yes  59 29 1.0 (0.6 to 1.5) 
Dermal nevus  
No  191 80 1.0 (referent) .16 
Yes  27 16 1.5 (0.9 to 2.5) 
Total sun exposure 
Light/moderate 109 43 1.0 (referent) .02  
Heavy/very heavy 108 50 0.6 (0.4 to 0.9) 
Severe sunburn 
No  81 39 1.0 (referent) .14 
Yes  142 59 0.7 (0.5 to 1.1) 
Sunlamp use    
No  189 89 1.0 (referent) <.01 
Yes  35 9 0.3 (0.2 to 0.7) 
Education 
Up to high school 111 47 1.0 (referent) .03 
Greater than  113 51 0.7 (0.4 to 1.0) 
high school 
Skin examination   
No  175 74 1.0 (referent) .60 
Yes  49 24 .9 (0.6 to 1.4) 
Skin awareness 
No   169 80 1.0 (referent) <.01 
Yes  55 18 0.5 (0.3 to 0.8) 
                                                 
3 Numbers may vary because of missing data for some variables. 
4 Age is continuous variable. 
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3.  Independent predictors of death from melanoma in a multivariable model.5 
 
 
Variable   Hazard ratio (95% confidence interval)   P value 
 
Number of nevi 
<30   1.0 (referent)  <.001 
30+   2.4 (1.5 to 3.7)  
Sex6 
Female   1.0 (referent)  .82 
Male   1.1 (0.7 to 1.6) 
Age at diagnosis   
1-year increase  1.03 (1.01 to 1.04)  <.001 
Anatomic site 
Other   1.0 (referent)  .01 
Head/Neck  2.0 (1.2 to 3.4)   
Solar elastosis 
Absent   1.0 (referent)  .01 
Present   0.6 (0.3 to 0.9) 
Breslow thickness 
< 0.76   1.0 (referent) 
≤3.60   3.1 (1.9 to 5.2)  <.001 
> 3.60   4.7 (2.6 to 8.5)  <.001 
Mitoses 
None   1.0 (referent)  <.001 
Any   4.2 (1.9 to 9.1) 
Dermal nevus 
No   1.0 (referent)  .04 
Yes   1.8 (1.0 to 3.3) 
Skin awareness 
No   1.0 (referent)  .01 
Yes   0.5 (0.3 to 0.9) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
5 This model was run with all variables with P < .15 in table 2.  Variables that remained statistically significant are shown. 
6 Sex was forced into the model. 
